MDS-605 Disease Modifying Activity of Imetelstat in Patients With Heavily Transfused Non-Del(5q) Lower-Risk Myelodysplastic Syndromes Relapsed/Refractory/Ineligible for Erythropoiesis-Stimulating Agents in IMerge Phase 3
Year: 2023
Type: conference-abstract
Authors: Valeria Santini, Uwe Platzbecker, Pierre Fenaux, Mikkael Sekeres, Michael Savona, Yazan Madanat, Maria Díez-Campelo, David Valcárcel-Ferreiras, Thomas Illmer, Anna JonáŠová, Petra Bělohlávková, Laurie Sherman, Tymara Berry, Souria Dougherty, Sheetal Shah, Qi Xia, Lixian Peng, Libo Sun, Ying Wan, Fei Huang, Annat Ikin, Shyamala Navada, Faye Feller, Amer Zeidan, Rami Komrokji
Institutions: Azienda Ospedaliero-Universitaria Careggi, University Hospital Leipzig, University of Florence, Yale Cancer Center, Yale University, Geron (United States), Université Paris Cité, Hôpital Saint-Louis, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, University of Miami, Sylvester Comprehensive Cancer Center, Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Vall d'Hebron Hospital Universitari, General University Hospital in Prague, University Hospital Hradec Králové, Moffitt Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4386271189